Skip to main content Skip to navigation

Lazaros Andronis

Job Title
WMS - Warwick Clinical Trials Unit
Research Interests

Dr Lazaros Andronis is a Reader in Health Economics and a Senior Member of the Centre for Health Economics at Warwick (CHEW) at the University of Warwick.

Dr Andronis' research draws on social sciences and health care research methods to answer economic questions about health and health care. Within this context, much of his research focuses on the methods and use of economic evaluation as a means of informing the allocation of limited resources across health care programmes, policies, treatments or technologies. He has significant experience in economic evaluation in health care, including cost-effectiveness and cost-utility analyses.

Dr Andronis has published his research in front-line health economics and medical journals, including Social Science and Medicine, Medical Decision Making, PharmacoEconomics, Quality of Life Research, European Journal of Health Economics, JAMA Oncology, Health Technology Assessment, British Medical Journal and he has authored publications commissioned by national bodies, educational material and monographs. He has presented his work in major health economics conferences, including meetings of the International Health Economics Association, European Health Economics Association and Health Economists' Study Group.

In 2021, Dr Andronis was awarded an NIHR Advanced Fellowship, a prestigious award that aims to support the development of outstanding researchers into international research leaders. As part of his Fellowship, Dr Andronis will bring together and lead a multidisciplinary team of collaborators to explore how best to identify the value that children and young persons place on their time and how to include this in health economic evaluations.

In addition to his NIHR Fellowship project, Dr Andronis currently leads or collaborates in the following ongoing projects.

  • The EPICE/SHIPS project. A large multinational study aiming to understand the socioeconomic determinants, the health care needs and the existing framework of care available to children born very prematurely across 11 EU states, with a view to establishing how resources can be allocated efficiently to support and promote children's health and wellbeing. Funded by the European Union's Horizon 2020 programme.
  • The BISTRO trial. Evaluation of the clinical and cost-effectiveness of bioimpedance analysis for fluid management in dialysis patients. PI: Prof S. Davies (Keele University). Funded by the NIHR HTA programme. Grant value: £1,420,988.
  • ROSSINI II. Evaluation of the cost-effectiveness of several novel surgical interventions aiming to reduce surgical site infection. PI: Prof T. Pinkney (University of Birmingham). Funded by the NIHR HTA programme. Grant value: £1,587,200
  • RECEDE trial. Evaluation of the effectiveness and cost-effectiveness of dual testing as a means of reducing colonoscopies in those without bowel disease. PI: Prof R. Arasaradnam (University of Warwick). Funded by the NIHR HS&DR. Grant value: £894,409
  • PAD optimization. Optimising the deployment of automated external defibrillators in public places in England. PI: Prof G. Perkins (University of Warwick). Funded by NIHR Health Services & Delivery Research. Grant value: £477.177.

In the past, as part of his role in Warwick Evidence, Dr Andronis led expert Evidence Review Groups commissioned by the National Institute for Health and Care Excellence to appraise the economic evidence in submissions for treatment authorization, reimbursement and availability in the NHS. In this role, Dr Andronis co-ordinated multidisciplinary teams of health economists, information specialists, clinical experts and systematic reviewers in appraising evidence and advising NICE on the cost-effectiveness of pharmaceuticals considered for adoption and reimbursement in the NHS.


Dr Andronis has a strong interest in teaching and learning activities. He currently leads and co-ordinates the teaching agenda for health economics in the Centre for Health Economics in WMS.

At Warwick, Dr Andronis leads the Introduction to Health Economics (MD990) module?the most substantial health economics teaching activity at WMS. This is one of the largest postgraduate modules in WMS, attracting over 40 students with backgrounds in a range of fields, spanning medicine and health services research to operational research and social sciences. Previously, as part of his role as a Lecturer in Health Economics at the University of Birmingham, Dr Andronis co-ordinated modules and delivered numerous lectures as part of the MSc in Health Economics and Health Policy.

Dr Andronis has taught health economics extensively to undergraduate and graduate students. He has supervised over 40 MSc dissertations, a number of which led to conference presentations and publications in health economics journals. At Warwick, Dr Andronis teaches health economics to undergraduate (3rd year BSc Economics, Department of Economics, Warwick) and postgraduate students (MSc Economics, Dept. of Economics and MPH, Warwick Medical School), and supervises postgraduate dissertation projects at WMS and the Department of Economics.

Dr Andronis is a Fellow of the Higher Education Academy (FHEA, since 2019), a Fellow of the Warwick International Higher Education Academy (WIHEA, since 2020) and a member of the WMS Academic Consultation and Advisory Panel for teaching. In 2019, Dr Andronis was awarded Monash Warwick Alliance Education Exchange funding to support a visit to Monash University in Australia, with a view to fostering closer teaching collaborations between CHEW and the widely acclaimed Centre for Health Economics at Monash.

In 2020, Dr Andronis was a winner of the Warwick Award for Teaching Excellence, an award celebrating outstanding contribution and leadership in education and teaching. w


Dr Andronis joined the University of Warwick in July 2017, as a Senior Research Fellow in Health Economics. Before his appointment at Warwick, Dr Andronis held the posts of Research Fellow (2006-2009), NIHR Doctoral Research Fellow (2009-2012) and Lecturer in Health Economics (2012-2017) at the Health Economics Unit of the University of Birmingham.

In the last 10 years, Dr Andronis has been involved in designing, coordinating and conducting methodological and applied health economics research funded by various national bodies, including NICE, NIHR and MRC. He has published in top-tier health economics and interdisciplinary journals and he has presented his work at international conferences and invited seminars.

Other roles and collegiate contribution includes:

  • Co-founder and co-lead convener: International Health Economics Association Special Interest Group in Economics of Children's Health and Wellbeing(2020 to date)
  • Panel member: NIHR Research for Patient Benefit (RfPB) North West Panel member (2017 to date)
  • Editorial Panel Member: Medical Decision Making (2017 to date)
  • NIHR Faculty Member (2009-2012)
  • NIHR Academy Member (2021 to date)
  • Scientific Committee Member: International Health Economics Association (iHEA) Congresses (2017 to date)
  • Member: NIHR/MRC TMRP Health Economics Working Group (2019 to date)
  • Fellow of the Higher Education Academy (2019 to date)
  • Fellow of the Warwick International Higher Education Academy (2020 to date)
  • Panel member: WMS Academic Consultation and Advisory Panel (2019 to date)
Title Funder Award start Award end
NIHR Advanced Fellowship: Estimating the value of children's time for use in economic evaluation National Institute for Health Research (NIHR DoH) 01 Feb 2022 31 Jan 2026
RECEDE study (Reducing Colonoscopies in those without bowEl DiseasE) HS&DR Stage 2 (Stage 1 - 60439) National Institute for Health Research (DoH) 01 May 2020 31 Oct 2022
NIHR HS&DR Full Stage: Optimisation of the Deployment of Automated External Defibrillators in Public Places in England National Institute for Health Research (DoH) 01 Oct 2019 30 Jun 2022
NIHR RfPB_Evaluation of the Care Companion_Variation to contract National Institute for Health Research (NIHR DoH) 01 Oct 2020 02 Apr 2022
NIHR TAR2 12 month extension and supplement - orginal award on IDEATE number 00169 under Aileen Clarke National Institute for Health Research (DoH) 01 Apr 2021 31 Mar 2022
NIHR RfPB Second Stage: PLANES via Liverpool National Institute for Health Research (DoH) 01 Apr 2019 31 Mar 2021
BioImpedance Spectroscopy to Maintain Renal Output: The BISTRO Trial National Institute for Health Research (DoH) 17 Jul 2017 31 Jan 2021